{"i":{"I3_ZNly5C":{"id":"I3_ZNly5C","type":"slide","setup":{"transparentBg":{"selectedKey":false},"bord":{"size":0,"rad":0},"bg":{"selectedKey":"fill","fill":{"opac":1,"rgb":"var(--TC3)"},"img":{"filt":{"opac":30,"gray":0,"blur":0,"tint":{"rgb":"#FFF","opac":0}},"pos":{"type":"crop","fit":{"bg":{"color":{"rgb":"#FFF","opac":100}},"vali":"center","hali":"center"},"crop":{"poi":{"x":552,"y":342}}},"measures":{"size":{"width":1080,"height":733}}}}}},"ArPEUMCgS5":{"id":"ArPEUMCgS5","type":"interactive","subtype":"interactiveRichText","setup":{"frmeTp":{"selectedKey":"noneFrame"},"bg":{"fill":{"opac":0,"rgb":"var(--TC3)"}},"vali":"top","paddV1":10,"rType":"richtext","txt":{"rType":"richtext","val":{"ops":[{"insert":"6 ","attributes":{"bold":true,"color":"#c0c5cb"}},{"insert":"Especificitats segons diagnòstics","attributes":{"bold":true,"color":"var(--TC2)"}},{"insert":"\n","attributes":{"size":"largeTitle"}},{"insert":" "},{"insert":"\n","attributes":{"size":"largeTitle"}},{"insert":"TRASTORNS PER CONSUM DE SUBSTÀCIES","attributes":{"bold":true,"color":"var(--TC1)"}},{"insert":"\n","attributes":{"size":"largeTitle"}}]}},"padd":22,"frmeColo":{"color":{"opac":1,"rgb":"var(--TC1)"}},"hali":""}},"FcTHTQuVVP":{"id":"FcTHTQuVVP","type":"interactive","subtype":"interactiveRichText","setup":{"frmeTp":{"selectedKey":"noneFrame"},"bg":{"fill":{"opac":0.2,"rgb":"#FFF"}},"txt":{"val":{"ops":[{"insert":"Tot i l’eficàcia dels tractaments, les taxes d’abstinència en aquesta població a llarg termini són modestes. Cal tenir en compte també l’increment del risc de convulsions associat al bupropió, en cas de pacients amb addicció a l’alcohol, però també cal destacar el seu efecte antidepressiu, important en aquest grup de pacients amb altres TCS, amb elevat risc de presentar un episodi depressiu (patologia dual). ","attributes":{"color":"#181d18"}},{"insert":"\n","attributes":{"align":"justify"}},{"insert":" ","attributes":{"color":"#181d18"}},{"insert":"\n","attributes":{"align":"justify"}},{"insert":"Cal integrar els tractaments per a la cessació del tabac en els programes de tractament d’altres substàncies. ","attributes":{"color":"#181d18"}},{"insert":"\n","attributes":{"align":"justify"}}]},"rType":"richtext"},"paddV1":10,"hali":""}},"flxztQK0w":{"id":"flxztQK0w","type":"interactive","subtype":"interactiveImage","setup":{"img":{"filt":{"opac":100,"gray":0,"blur":0,"tint":{"rgb":"#FFF","opac":0}},"pos":{"type":"crop","fit":{"bg":{"color":{"rgb":"#FFF","opac":100}},"vali":"center","hali":"center"},"crop":{"bg":{"color":{"rgb":"#FFF","opac":0}},"poi":{"x":763,"y":500}},"mask":{"shape":1}},"measures":{"size":{"width":1500,"height":1000}},"orig":{"rType":"asset","rSubType":"image","fileName":"minimal-medicinal-pills-arrangement.jpg","fileSize":1089448,"val":"mc-fe675181a9f76a9d739d9d64213c24b8.jpg","aid":"ZQytFHT8U"}}}}},"v":"1"}